# A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants

> **NCT05051553** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 58 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Fedratinib

## Key facts

- **NCT ID:** NCT05051553
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2021-12-23
- **Final completion:** 2022-04-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051553, "A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05051553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*